-
Evaluation of the Neuroprotectivity Ability of Zymes' Water-soluble CoQ10 (WS-CoQ10) in Pre-clinical Models of PD; Preclinical Validation and Dose Optimization for Clinical Study
… can be re-capitulated in pre-clinical models as a result of systemic injections of certain neurotoxins. The researchers …
-
Caspase- 1 Inhibition to Reduce Cleaved Alpha-synuclein in Pre-clinical Models of Parkinson's Disease
… within the SN and restore impaired function of the dopamine system in two pre-clinical models of Parkinson’s disease …
-
Assessing the Role of Glucosylceramide in Alpha-synuclein-induced Toxicity
… them amenable to degradation through cellular clearance systems. Hypothesis: GluCer-reducing agents will prevent the …
-
On Your Feet: Addressing Gait and Balance Issues in Parkinson's
January 17, 2019
… by adding a password. Your information is already in our system. Login here to register. Register Thank you for your …
-
Better Conversations and Care: How Patients and Doctors Can Work Together
March 21, 2019
… by adding a password. Your information is already in our system. Login here to register. Register Thank you for your …
-
Novel alpha-Synuclein Isomers as Immunogens for Immunotherapy of Parkinson Diseases
… of alpha-synuclein (a normal protein expressed in nervous system) in the brain has been shown to contribute to the …